Skip to main content
. 2022 Oct 6;10(28):10004–10016. doi: 10.12998/wjcc.v10.i28.10004

Table 2.

Protective effect of astragaloside IV on the brain and nervous system

Disease categories
Study object/model
Effect induced by autophagy
Mechanism (targets or pathways)
Ref.
Ischemic stroke MCAO in SD rats; OGD/R in HT22 cells A neuroprotective role (-) apoptosis (+) autophagy (+) cell viability, balanced Bcl-2 and Bax expression, (-) the rate of apoptosis, (-) p62, (+) LC3 II/LC3 I Zhang et al[27]
Acute ischaemic stroke Acute ischaemic stroke mice (-) The abnormal intestinal microbial; (-) ROS, homocysteine and FFA, NOX2/4, and autophagy marker (-) Autophagy-related gene (Beclin 1, LC3 II, Atg 12 Xu et al[28]
Ischemic stroke OGD/R in PC12 cells (-) Excessive autophagy and damage in PC12 cells The PI3K I/Akt/mTOR and PI3K III/Becline-1/Bcl-2 signalling pathways Huang et al[30]
Spinal cord injury Vascular clip to clamp the spinal cord in SD rats (+) Functional recovery in the spinal cord; (-) apoptosis via (+) autophagy in neuronal cells (-) mTORC1 (+) lysosomal biogenesis through TFEB Lin et al[29]
Parkinson’s disease MPTP-induced PD mouse model (-) The loss of dopamine neurons and behavioural deficits; (+) mitophagy (-) Damaged mitochondria accumulation, (-) mitochondrial ROS generation Xia et al[31]

MCAO: Middle cerebral artery occlusion; OGD/R: Oxygen and glucose deprivation/reoxygenation; PC12: A neuron cell line; LC: Lung cancer; ROS: Reactive oxygen species; FFA: Free fatty acids; NOX: NADPH oxidases; Atg: Autophagy; MPTP: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD: Parkinson’s disease.